InflaRx (IFRX) Stock Chart & Stock Price History $1.06 +0.01 (+0.95%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.06 0.00 (0.00%) As of 04/17/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock InflaRx Stock Price Performance 5 Day Performance+14.72%1 Month Performance-13.11%3 Month Performance-58.27%6 Month Performance-31.61%Year-To-Date Performance-57.09%1 Year Performance-16.21% Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. Email Address IFRX Stock Chart for Friday, April, 18, 2025 IFRX Chart by TradingView InflaRx Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/16/2025$1.10$1.05-4.55%$1.12$1.0190,156 shs$70.49 million04/15/2025$0.98$1.10+12.26%$1.11$0.98313,787 shs$73.85 million04/14/2025$0.92$0.98+6.05%$1.04$0.91435,012 shs$65.78 million04/11/2025$0.90$0.92+2.67%$0.96$0.87174,453 shs$62.03 million04/10/2025$0.93$0.90-3.11%$1.06$0.86420,495 shs$60.42 million04/09/2025$0.94$0.93-0.75%$1.01$0.82840,195 shs$62.36 million04/09/2025$0.94$0.93-0.75%$1.01$0.82840,195 shs$62.36 million04/08/2025$1.01$0.94-7.34%$1.09$0.92234,597 shs$62.83 million04/08/2025$1.01$0.94-7.34%$1.09$0.92234,597 shs$62.83 million04/07/2025$1.01$1.01$1.10$0.90450,536 shs$67.80 million Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 04/04/2025$1.05$1.01-3.81%$1.10$0.97319,785 shs$67.80 million04/03/2025$1.15$1.05-8.70%$1.09$1.04172,369 shs$70.49 million04/02/2025$1.05$1.15+9.52%$1.18$1.05281,282 shs$77.20 million04/01/2025$1.02$1.05+2.94%$1.09$1.01565,759 shs$70.49 million03/31/2025$1.15$1.02-11.30%$1.30$1.02835,572 shs$68.48 million03/28/2025$1.25$1.15-8.00%$1.28$1.14346,085 shs$77.20 million03/27/2025$1.24$1.25+0.81%$1.31$1.20263,607 shs$83.92 million03/26/2025$1.33$1.24-6.77%$1.40$1.24402,847 shs$83.25 million03/25/2025$1.41$1.33-5.67%$1.41$1.32108,974 shs$89.29 million03/24/2025$1.28$1.41+10.16%$1.42$1.26496,668 shs$94.66 million03/21/2025$1.26$1.28+1.59%$1.29$1.24208,597 shs$85.93 million03/20/2025$1.28$1.26-1.56%$1.31$1.16293,575 shs$84.59 million03/19/2025$1.21$1.28+5.79%$1.31$1.19557,062 shs$85.93 million03/18/2025$1.22$1.21-0.82%$1.25$1.16229,231 shs$81.23 million03/17/2025$1.19$1.22+2.52%$1.27$1.14427,988 shs$81.90 million Related Companies Cartesian Therapeutics Stock Chart 2seventy bio Stock Chart Aquestive Therapeutics Stock Chart Taysha Gene Therapies Stock Chart Astria Therapeutics Stock Chart Atyr PHARMA Stock Chart Atai Life Sciences Stock Chart COMPASS Pathways Stock Chart Monte Rosa Therapeutics Stock Chart Arcturus Therapeutics Stock Chart Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IFRX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx Please log in to your account or sign up in order to add this asset to your watchlist. Share InflaRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.